353 related articles for article (PubMed ID: 37227120)
21. Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma.
Li J; Ran H; Zeng X; Yang D; Zeng X; Zhang P
Medicine (Baltimore); 2023 Sep; 102(35):e35035. PubMed ID: 37657018
[TBL] [Abstract][Full Text] [Related]
22. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.
Abdel-Fatah TM; Russell R; Albarakati N; Maloney DJ; Dorjsuren D; Rueda OM; Moseley P; Mohan V; Sun H; Abbotts R; Mukherjee A; Agarwal D; Illuzzi JL; Jadhav A; Simeonov A; Ball G; Chan S; Caldas C; Ellis IO; Wilson DM; Madhusudan S
Mol Oncol; 2014 Oct; 8(7):1326-38. PubMed ID: 24880630
[TBL] [Abstract][Full Text] [Related]
23. PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.
Li X; Li X; Hu Y; Liu O; Wang Y; Li S; Yang Q; Lin B
BMC Cancer; 2023 Jun; 23(1):573. PubMed ID: 37349676
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Role of microRNA-205 in Human Gynecological Cancer: A Meta-Analysis of Fourteen Studies.
Wu Z; Tang H; Xiong Q; Liu D; Xia T; Liang H; Ye Q
DNA Cell Biol; 2020 May; 39(5):875-889. PubMed ID: 32354230
[TBL] [Abstract][Full Text] [Related]
25. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
[TBL] [Abstract][Full Text] [Related]
26. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
[TBL] [Abstract][Full Text] [Related]
27. Pan-cancer analysis of the prognostic and immunological role of Fanconi anemia complementation group E.
Zhou Z; Yin H; Suye S; He J; Fu C
Front Genet; 2022; 13():1024989. PubMed ID: 36685883
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma.
Aotsuka A; Matsumoto Y; Arimoto T; Kawata A; Ogishima J; Taguchi A; Tanikawa M; Sone K; Mori-Uchino M; Tsuruga T; Oda K; Kawana K; Osuga Y; Fujii T
Cancer Sci; 2019 Oct; 110(10):3068-3078. PubMed ID: 31432577
[TBL] [Abstract][Full Text] [Related]
29. ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma.
Zhang Q; Wang Y; Xue F
Genet Res (Camb); 2022; 2022():3217248. PubMed ID: 36186000
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
31. KLHL14, an ovarian and endometrial-specific gene, is over-expressed in ovarian and endometrial cancer.
Han M; Yang HJ; Lin Q
Math Biosci Eng; 2019 Dec; 17(2):1702-1717. PubMed ID: 32233603
[TBL] [Abstract][Full Text] [Related]
32. Endometrial cancers in mutation carriers from hereditary breast ovarian cancer syndrome kindreds: report from the Creighton University Hereditary Cancer Registry with review of the implications.
Casey MJ; Bewtra C; Lynch HT; Snyder CL; Stacey M
Int J Gynecol Cancer; 2015 May; 25(4):650-6. PubMed ID: 25756400
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
Shinden Y; Hirashima T; Nohata N; Toda H; Okada R; Asai S; Tanaka T; Hozaka Y; Ohtsuka T; Kijima Y; Seki N
J Hum Genet; 2021 May; 66(5):519-534. PubMed ID: 33177704
[TBL] [Abstract][Full Text] [Related]
34. Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation.
Huang HN; Chiang YC; Cheng WF; Chen CA; Lin MC; Kuo KT
Mod Pathol; 2015 Feb; 28(2):303-11. PubMed ID: 25081752
[TBL] [Abstract][Full Text] [Related]
35. Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study.
Hong CQ; Zhang F; You YJ; Qiu WL; Giuliano AE; Cui XJ; Zhang GJ; Cui YK
BMC Cancer; 2015 Jul; 15():548. PubMed ID: 26209438
[TBL] [Abstract][Full Text] [Related]
36. Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many Cancers.
Qureshi MA; Khan S; Tauheed MS; Syed SA; Ujjan ID; Lail A; Sharafat S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3199-3209. PubMed ID: 33247676
[TBL] [Abstract][Full Text] [Related]
37. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
[TBL] [Abstract][Full Text] [Related]
38. Distinct prognostic values of four-Notch-receptor mRNA expression in ovarian cancer.
Zhou X; Teng L; Wang M
Tumour Biol; 2016 May; 37(5):6979-85. PubMed ID: 26662955
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma.
Zhang H; Kong W; Zhao X; Xie Y; Luo D; Chen S
BMC Med Genomics; 2023 Feb; 16(1):29. PubMed ID: 36803157
[TBL] [Abstract][Full Text] [Related]
40. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
